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Mitochondrial DNASeveral human neurological disorders have been associated with various mutations affecting mitochondrial
enzymes involved in cellular ATP production. One of these mutations, T9176C in the mitochondrial DNA
(mtDNA), changes a highly conserved leucine residue into proline at position 217 of the mitochondrially
encoded Atp6p (or a) subunit of the F1FO-ATP synthase. The consequences of this mutation on the
mitochondrial ATP synthase are still poorly deﬁned. To gain insight into the primary pathogenic mechanisms
induced by T9176C, we have investigated the consequences of this mutation on the ATP synthase of yeast
where Atp6p is also encoded by the mtDNA. In vitro, yeast atp6-T9176C mitochondria showed a 30%
decrease in the rate of ATP synthesis. When forcing the F1FO complex to work in the reverse mode, i.e. F1-
catalyzed hydrolysis of ATP coupled to proton transport out of the mitochondrial matrix, the mutant showed
a normal proton-pumping activity and this activity was fully sensitive to oligomycin, an inhibitor of the ATP
synthase proton channel. However, under conditions of maximal ATP hydrolytic activity, using non-
osmotically protected mitochondria, the mutant ATPase activity was less efﬁciently inhibited by oligomycin
(60% inhibition versus 85% for the wild type control). Blue Native Polyacrylamide Gel Electrophoresis
analyses revealed that atp6-T9176C yeast accumulated rather good levels of fully assembled ATP synthase
complexes. However, a number of sub-complexes (F1, Atp9p-ring, unassembled α-F1 subunits) could be
detected as well, presumably because of a decreased stability of Atp6p within the ATP synthase. Although the
oxidative phosphorylation capacity was reduced in atp6-T9176C yeast, the number of ATP molecules
synthesized per electron transferred to oxygen was similar compared with wild type yeast. It can therefore
be inferred that the coupling efﬁciency within the ATP synthase was mostly unaffected and that the T9176C
mutation did not increase the proton permeability of the mitochondrial inner membrane.: +33 5 56 99 90 51.
di Rago).
ll rights reserved.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Most of the ATP in human cells is produced by an F1FO-type ATP
synthase or complex V located in the mitochondrial inner membrane
[1]. This enzyme utilizes the energy of the electrochemical proton
gradient established by the mitochondrial electron transport chain to
drive the synthesis of ATP from ADP and inorganic phosphate.
Pronounced defects in the ATP synthase can be responsible for various
very deleterious disorders in humans, especially in the highly energy-demanding neuromuscular system [2–4]. Such disorders like NARP
(neuropathy ataxia retinitis pigmentosa) and MILS (maternally-
inherited Leigh's syndrome) have been associated to several muta-
tions in the mitochondrial ATP6 gene encoding subunit a of the ATP
synthase (referred to as Atp6p in yeast). This subunit contains most of
the residues involved in the proton translocating activity of the FO
domain of the ATP synthase [5]. Proton movements mediated by
subunit a lead to the rotation of a ring of c subunits (referred to as
Atp9p in yeast) that contacts subunit a in the membrane. The
resulting mechanical energy is then used to induce conformational
changes at the level of the catalytic sites in the F1 extra-membrane
domain of the enzyme that favor the synthesis of ATP and its
subsequent release into the mitochondrial matrix.
Fig. 1. The T9176C mutation (atp6-L247P) does not compromise the growth of yeast on
respiratory substrates. Freshly grown cells of wild type yeast (MR6) and atp6-L247P
mutant (RKY38) were serially diluted and 5 µl of each dilution were spotted onto YPGA
(glucose) and N3 (glycerol) plates. The plates were incubated at 28 °C and
photographed after three (YPGA) or six (N3) days.
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replacement of a highly conserved leucine into proline at amino acid
position 217 of subunit a [6,7]. Despite unequivocal genetic evidence
for the pathogenicity of this mutation, its consequences on mito-
chondrial ATP synthase are still poorly deﬁned. We recently reported
the construction and properties of yeast models of other pathogenic
mutations found in the human ATP6 gene: T9176G [8], T8993G [9]
and T8993C [10]. The yeast and human ATP synthases proved to be
similarly affected by thesemutations, which is not very surprising due
to the high conservation of the mitochondrial ATP synthase in terms
of structure and function [4]. To gain insight into the primary patho-
genic mechanisms of T9176C, we have investigated the consequences
of this mutation on the yeast ATP synthase.
2. Experimental procedures
2.1. Yeast strains and media
The S. cerevisiae strains and their genotypes are listed in Table 1.
The preparation of rich media containing glucose, glycerol, or galac-
tose carbon sources, and synthetic complete drop-out media supple-
mented with adenine to 40 mg/L, was as described [11]. Where
indicated, ethanol (2%) was included with glycerol (3%) to prepare
enriched plates with two non-fermentable substrates (EG). Oligomy-
cin was added to media as indicated in the legend to Fig. 5.
2.2. Construction of atp6-L247P mutant strains
The mutagenesis was performed on an EcoRI-BamHI C-terminal
fragment of the yeast ATP6 locus cloned in pUC19 (plasmid pSDC9, [11]).
This fragment contains the 38 codons of the 3′ end of ATP6 gene (codons
233–260). Using the QuikChange XL Site-directed Mutagenesis Kit from
Stratagene, the TTA codon 247 of ATP6 genewas changed into the proline
CCA codonwith the following primers: 5′GGATATGTCTGGGCTATTCCAA-
CAGCATCATATTTA, and 5′ TAAATATGATGCTGTTGGAATAGCCCAGACA-
TATCC (the mutated bases are in bold). The mutated fragment was
cleaved fromtheplasmidbyEcoRI/SapI digestion andcloned intopSDC14
using the same sites, to create pRK8plasmid,which encodes awholeATP6
gene containing the L247Pmutation. The pRK8 plasmid contains also the
yeast mitochondrial COX2 gene as a marker for mitochondrial transfor-
mation [9]. The pRK8 plasmid was introduced by co-transformation with
the nuclear selectable LEU2 plasmid pFL46 into the ρ° strain DFS160 by
microprojectile bombardment using a biolistic PDS-1000/He particle
delivery system (Bio-Rad) as described [12].Mitochondrial transformants
were identiﬁed among the Leu+ nuclear transformants by their ability toTable 1
Genotypes and sources of yeast strains.
Strain Nuclear genotype
DFS160 MATα leu2Δ ura3-52 ade2-101 arg8::URA3 kar1-1
NB40-3C MATa lys2 leu2-3,112 ura3-52 his3ΔHinDIII arg8::hisG
SDC30 Matα, kar1, ade2, ura3, leu2, Δarg8 : :URA3
MR6 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 a
MR10 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 a
RKY37 MATα leu2Δ ura3-52 ade2-101 arg8::URA3 kar1-1
RKY38 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 a
RKY20 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 a
RKY25 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 a
RKY48 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 a
W303-1A MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1
W303ΔATP11 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 ATP11::
Atp11(Δ40-75)p MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 ATP11::
Atp11(Δ40-111)p MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 ATP11::
Atp11(R183)p MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 ATP11::
Atp11(A300)p MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 ATP11::
a, Rothstein.produce respiring cloneswhenmated to the nonrespiringNB40-3C strain
bearing a deletion in the mitochondrial COX2 gene. One mitochondrial
transformant (synthetic ρ− RKY37) was crossed to the atp6::ARG8m
deletion strain MR10 (Table 1, see also ref. [11]). The crosses produced
cytoductants (called RKY38) harboring the MR10 nucleus and mtDNA in
which the ARG8m ORF had been replaced with the atp6-L247P gene. The
RKY38 clones were identiﬁed by virtue of their inability to grow in the
absence of an external source of arginine. Sequencing of themutatedatp6
locus in RKY38 revealed no change other than L247P.2.3. Miscellaneous procedures
Determination of ρ−/ρ° cells in yeast cultures, mitochondrial
respiratory and ATP synthesis/hydrolysis activities, mitochondrialmtDNA Source
ρ° [39]
ρ+cox2-62 [39]
ρ− ATP6 COX2 [11]
rg8::HIS3 ρ+ WT [11]
rg8::HIS3 ρ− atp6::ARG8m [11]
ρ− atp6-L247P This study
rg8::HIS3 ρ+ atp6-L247P This study
rg8::HIS3 ρ+ atp6-L183P [10]
rg8::HIS3 ρ+ atp6-L247R [8]
rg8::HIS3 ρ+ atp6-Δleader [20]
ρ+ a
HIS3 ρ+ [40]
HIS3 [URA3-pG13/Δ40-75s] ρ+ [22]
HIS3 [URA3-pG13/Δ40-111 s] ρ+ [22]
HIS3 [URA3-pG13/R183m] ρ+ [22]
HIS3 [URA3-pG13/A300m] ρ+ [22]
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SDS- and BN-PAGE, and pulse labeling of mtDNA encoded proteins
were performed as described in [11] and references therein.
3. Results
3.1. Genetic stability and respiratory growth of yeast mutant atp6-L247P
The leucine residue 217 of human subunit a that is changed into
proline by the T9176C mutation corresponds to the leucine residue
247 of the yeast homologous protein Atp6p [4]. We have converted
the TTA triplet encoding this residue into the CCA codon for proline
(see Experimental procedures). In view of earlier ﬁndings that
mutations of the ATP synthase often promote instability of the
mitochondrial genome in yeast in the form of ρ− clones issued from
large deletions in the mtDNA [13], two independent atp6-L247P
isolates of the mutant RKY38 (Table 1) were tested for the percentage
of ρ− cells in cultures grown under non-selective conditions, in rich
glucose or galactose medium. These cultures contained only 2%
secondary ρ− cells like those of the corresponding wild type strain
(MR6), indicating that the leucine to proline change did not adversely
affect the stability of yeast mtDNA.
The atp6-L247Pmutant grew nearly identically to the wild type on
a non-fermentable substrate (glycerol) both at 28 °C, the optimal
temperature for growing yeast (Fig. 1), and at 36 °C (not shown). This
does not imply that the atp6-L247P mutation had no deleterious
effects on the ATP synthase. Instead, it is necessary to decrease the
rate of ATP synthesis by ∼85% to observe an obvious growth defect on
non-fermentable substrates ([14] and see below).
3.2. Consequences of the atp6-L183P mutation on several activities
related to respiration and oxidative phosphorylation.
3.2.1. Oxygen consumption
Mitochondria isolated from the atp6-L247P mutant and from the
corresponding wild type strain MR6 were assayed for oxygen
consumption. With NADH as an electron donor, the basal (state 4)
oxygen consumption rate was about the same for the two strains
(Table 2). The respiratory rates were stimulated in the presence of
excess ADP (state 3 or phosphorylating conditions), but the effect was
more pronounced in wild type mitochondria (2.2-fold) compared to
the mutant sample (1.6-fold). A qualitatively similar result was
observed when maximal respiratory rates were measured in the
presence of the uncoupler, m-chlorophenylhydrazone (CCCP), in
which case oxygen consumption increased 3.9-fold and 2.9-fold,
respectively, in wild type and mutant mitochondria (Table 2).
Notably, while the rates of stimulated oxygen consumption were
lower in the mutant versus wild type mitochondria, the magnitude of
the effect produced by CCCP was ∼1.3-fold greater relative to ADP in
both samples. This ﬁnding suggests that the atp6-L247P mutation
caused a decrease in the content of respiratory enzymes rather than a
modiﬁcation of the passive proton permeability of the inner mito-
chondrial membrane.Table 2
Inﬂuence of the atp6-L247P mutation on yeast mitochondrial respiration, ATP hydrolytic, a
Strain Respiration rates nmol O min−1 mg−1
NADH NADH + ADP NADH + CCCP Asc/TMPD +
MR6 279±17 613±12 1081±107 2013±290
RKY38 274±23 428±26 798±45 1313±121
Mitochondria were isolated from wild type strain MR6 (WT) and mutant atp6-L247P (RKY3
were 0.15 mg/ml proteins, 4 mM NADH, 150 μM ADP, 12.5 mM ascorbate (Asc), 1.4 mM N,N
The MR6 and RKY38 both cultures contained 2% ρ−/ρ° cells. The values reported are average
measured using freshly isolated mitochondria in iso-osmotic buffer (Mannitol 0.6 M, EGT
mitochondria (kept at −80 °C) were thawed and the reaction was analyzed in a hypo-osmOur previous investigations of other yeast models of NARP/MILS
diseases (atp6-L183P [10], atp6-L183R [9] and atp6-L247R [8]), and of
an ATP6-deletion strain (Δatp6) [11], revealed a deﬁcit for cytochrome
c oxidase (complex IV) in each of the mitochondrial samples and
correlated the magnitude of this effect with the degree of respiratory
deﬁciencymeasured for eachmutant strain (see Discussion). A similar
relationship between the level of complex IV and respiratory function
was demonstrated also for the atp6-L247P mutant in the current
work. Measurements of oxygen consumption, in the presence of
substrates that donate electrons directly to complex IV (ascorbate/
TMPD), showed that this activity was reduced in the mutant 35% with
respect to wild type (Table 2). Consistent with this ﬁnding, dithionite-
reduced spectra recorded from whole cells showed that cytochromes
a + a3 of complex IV were decreased ∼30% in the mutant compared
with wild type, while cytochromes c1 and b of complex III were in
normal amounts (data not shown). Finally, the amount of immuno-
logically reactive complex IV protein in mutant mitochondria was
substantially below the wild type level (see Fig. 2A for a typical result
representative of three independent experiments).
3.2.2. Mitochondrial ATP synthesis/hydrolysis
The consequences of the atp6-L247P mutation were analyzed
further by measuring the rate of mitochondrial ATP synthesis with
NADH as a respiratory substrate. This activity was reduced in the
mutant by ∼30% compared with the wild type (Table 2), which was
similar in scale to the difference observed between these samples
with respect to rates of oxygen consumption that were measured
under identical conditions (see above). Hence, the efﬁciency of
oxidative phosphorylation, as deﬁned by the number of ATP
molecules formed per electron transferred to oxygen, appeared to
be largely unaffected by the atp6-L247P mutation. The rate of ATP
hydrolysis measured in mitochondria from the atp6-L247P mutant
was ∼75% the wild type level (Table 2). Of particular interest,
oligomycin inhibited the ATPase activity by 85% in the wild type
sample, but only by 60% in the mutant sample.
3.2.3. ATP-driven translocation of protons across the inner mitochondrial
membrane
The proton-pumping activities of wild type and atp6-L247P
mutant F1FO were measured in samples of whole mitochondria
using a ﬂuorescent dye, Rhodamine 123, to monitor changes in the
membrane potential (ΔΨ) (Fig. 3); the dye accumulates inside the
mitochondrial matrix, where its ﬂuorescence is quenched, in
response to an established ΔΨ [15]. Before testing for ATP-driven
proton translocation, the mitochondria were energized with ethanol
in order to effect the release of the natural inhibitory peptide (IF1)
that binds F1FO in the resting state and prevents ATP hydrolysis (Fig. 3,
EtOH). The imposed ΔΨ was then collapsed with KCN, and before
rebinding of IF1 could occur (see ref. [16]). ATP was added and
counter-exchanged for ADP in the matrix compartment. Comparable
levels of proton pumping coupled to ATP hydrolysis were manifested
in the wild type and mutant mitochondria by a large and sustainednd ATP synthesis activities.
ATPase activity nmol Pi min−1 mg−1 ATP synthesis rate
nmol Pi min−1 mg−1
CCCP − oligo + oligo − oligo + oligo
4.474±0.222 0.665±0.108 637±18 15±8
3.324±0.405 1.292±0.229 475±18 23±0.3
8), grown for 5–6 generations in YPGALA medium (rich galactose) at 28 °C. Additions
,N,N,-tetramethyl-p-phenylenediamine (TMPD), 4 μM CCCP, 3 μg/ml oligomycin (+O).
s of triplicate assays±standard deviation. Respiratory and ATP synthesis activities were
A 0.3 mM, Tris/Maleate 10 mM) at pH 6.8. For the ATPase assays, previously frozen
otic solution (KCl 0.2 M, MgCl2 10 mM, Tris/HCl 10 mM) at pH 8.4.
Fig. 2. SDS- and BN-PAGE analyses of mitochondrial proteins from atp6-L247P mutant.
Panels A, B: BN-PAGE analyses of mitochondrial proteins from the yeast T9176C (atp6-
L247P). For the analysis of complexes III and IV (panel A) the mitochondria (100 μg)
were solubilized with 10 g of digitonin per gram of proteins while 2 g of digitonin per
gram of proteins were used for the analysis of the ATP synthase (Panel B). After their
electrophoretic separation the digitonin-extracted proteins (50 μg) were transferred to
a nitrocellulose membrane and hybrized with the indicated antibodies. For the blots
shown in panel B, between two hybridizations, the membrane was stripped to
completely remove the previously hybridized antibodies. Panel C, SDS-PAGE analysis.
Total mitochondrial proteins (10 μg) of atp6-L247P mutant and wild type strain MR6
were separated in SDS-PAGE, transferred onto a nitrocellulose membrane and probed
with the indicated antibodies. Data are representative of at least 3 experiments.
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oligomycin (Fig. 3, oligo).
3.3. Assembly/stability of the ATP synthase in the atp6-L247P mutant
Blue native polyacrylamide gel electrophoresis (BN-PAGE) was
used to examine the inﬂuence of the atp6-L247P mutation on the
assembly and stability of the ATP synthase (Fig. 2). Following
electrophoretic separation, digitonin-extracted mitochondrial pro-
teins were transferred to nitrocellulose and hybridized, successively,
with antibodies against four subunits representative of different ATP
synthase domains, the proton channel (Atp6p, Atp9p), the peripheral
stalk (Atp7p) and the F1 unit (Atp1p or subunit α). The antibodiesagainst Atp6p and Atp7p detected two immunological signals at
comparable levels in mitochondria from the wild type and atp6-L247P
strains, corresponding to fully assembled F1FO dimers and monomers
(Fig. 2B). However, the two samples were distinguished with anti-
bodies against Atp9p and subunitα (Atp1p), which detected evidence
of an Atp9p-ring, free F1, and incomplete α subunit assemblies in the
mutant sample only (Fig. 2B). Pulse-chase analysis of mitochondrial
translation products in isolatedmitochondria revealed that Atp6pwas
synthesized with similar efﬁciencies in the atp6-L247P and wild type
organelles and that there was no difference between the two in the
turnover rates for newly synthesized mitochondrial gene products
(Fig. 4). Consistent with these ﬁndings, Western blots of SDS-PAGE
gels showed equivalent steady-state levels of Atp6p, Atp9p and
subunit α in the wild type and mutant samples (Fig. 2C). Taken
together, these data indicated only a modest effect of the atp6-L247P
mutation on ATP synthase biogenesis and stability.
3.4. The atp6-L47P mutant is more sensitive to oligomycin in vivo than
the wild type
A previous report [14] indicated that the ATP synthase is far from
being limiting for yeast proliferation on non-fermentable substrates
(e.g. glycerol); rather the activity of the enzyme needs to be decreased
by ∼85% before non-fermentative growth is inhibited. Hence, it is not
surprising that yeast models of atp6-L247P and atp6-L183P mutations
(Table 1) showed ∼wild type growth on glycerol plates (Fig. 1A),
despite a 30% and 40% deﬁcit, respectively, in mitochondrial ATP
production (Table 2, [10]). However, since the atp6-L183P and atp6-
L247P mutants are compromised for oxidative phosphorylation, we
reasoned that the viability of these strains on glycerol might be more
sensitive to oligomycin than wild type yeast. This prediction was
validated in experiments that showed the atp6-L247P mutant ceased
to grow on glycerol in the presence of an oligomycin concentration
(0.25 μg/ml) that did not interfere signiﬁcantly with wild type
propagation on this medium (Fig. 5A). The atp6-L183P mutant
showed a similar phenotype on oligomycin-supplemented glycerol
plates (data not shown).
Interpretation of these results was complicated by the fact that
several mutations in Atp6p were shown to render the yeast ATP
synthase more resistant to oligomycin [17,18]. Perhaps the atp6-
L183P and atp6-L247P mutations affected the binding of oligomycin
in a way that enhanced, rather than reduced, sensitivity; e.g. by
decreasing the dissociation constant of the drug. Hence, it was
deemed useful to measure oligomycin sensitivity in vivo for additional
yeast mutants that showed a 50–80% deﬁcit in mitochondrial ATP
sythase activity, and which were known to be unaffected in the
oligomycin binding pocket. One such mutant lacked the leader
peptide of Atp6p (strain RKY48, Table 1) that encompasses the N-
terminal 10 amino acids of the full-length gene product, and which is
cleaved during the assembly of Atp6p into FO [19].While not essential,
this peptide enhanced the association of Atp6pwith the Atp9 (subunit
c)-ring [20]. The leaderless mutant (RKY48), which showed a 50%
reduction in ATP production, grew normally on plain glycerol plates
but was more sensitive than the wild type to oligomycin (Fig. 5A). We
also examined atp11 mutants in this work. Although Atp11p is not
part of the F1FO complex, this protein is required for assembly of the β-
subunit into the F1 sector and its absence renders yeast respiratory
defective [21]. The mutants investigated in this work were disrupted
at the ATP11 locus (Δatp11), produced N-terminal or C-terminal
deleted forms of Atp11p from episomal plasmids, and displayed
mitochondrial ATP synthase activity above the threshold (15%) that is
required to sustain growth on non-fermentable carbons [22]. None of
these atp11 mutants grew on ethanol–glycerol plates that were
supplemented with 0.2% oligomycin while the wild type parental
strain was unaffected in this respect (Fig. 5B). These results indicate
that an increased sensitivity in vivo to oligomycin can be caused by
Fig. 3. Energization of mitochondria. Energization of the mitochondrial inner membrane was monitored by rhodamine 123 ﬂuorescence quenching with intact mitochondria from
wild type yeast (MR6) and atp6-L247P mutant (RKY38). The additions were 0.5 μg/ml rhodamine 123, 0.15 mg/ml mitochondrial proteins (Mito), 10 μl of ethanol (EtOH), 6 μg/ml
oligomycin (oligo), 0.2 mM potassium cyanide (KCN), 1 mM ATP, and 3 μM CCCP. Data are representative of at least 3 experiments.
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perties of the oligomycin binding pocket itself.
4. Discussion
The present study describes a yeast model that has investigated
the consequences imposed by the T9176C mutation of human mtDNA
that was identiﬁed in NARP/MILS patients. This mutation leads to
replacement of a highly conserved leucine residue into proline within
the Atp6p (subunit a) of the ATP synthase (at position 217 in humans,
247 in yeast). Current models predict this residue is located within an
α-helical trans-membrane segment that is in close proximity to the
Atp9p (or subunit c)-ring near residues (c-D61 and a-R159), which
are known to be critical for FO activity [23]. Introducing an α-helix
breaker proline residue is this region could conceivably affect the
interactions of Atp6pwith Atp9p and/or the functioning of the Atp9p-
ring/Atp6p system.Fig. 4. Inﬂuence of the atp6-L247P mutation on mitochondrial protein synthesis.
Proteins encoded by the mtDNA were in vivo labeled with [35S]-(methionine +
cysteine) for 20 min at 28 °C in the presence of cycloheximide to inhibit cytosolic
protein synthesis. Turnover of newly synthesized proteins was evaluated by the
addition of excess cold (methionine + cysteine) and incubation for the indicated
periods of time. After the labeling reactions, total protein extracts were prepared from
the cells (0.2 OD at 650 nm) and loaded on a 12.5% polyacrylamide-4 M urea gel
containing 25% glycerol. After electrophoresis the gel was dried and radioactive
proteins visualized with a phosphoImager.
Fig. 5. The T9176C mutation (atp6-L247P) renders the growth of yeast on respiratory
substrates more sensitive to oligomycin. Panel A: freshly grown cells of wild type
yeast (MR6), atp6-L247P mutant (RKY38), and a strain lacking the leader peptide of
Atp6p (RKY48, atp6-Δleader) [20] were serially diluted and 5 μl of each dilution spotted
onto glucose and glycerol plates, and onto glycerol plates containing the indicated
concentrations of oligomycin (Oligo). The plates were incubated at 28 °C and
photographed after 4 days. Panel B: growth of yeast atp11mutants on EG± oligomycin.
Wild type and atp11 mutant strains described in [22] were grown overnight on rich
glucose plates (2% glucose, 2% bactopeptone, 1% yeast extract), replica-plated to non-
fermentable media (3% glycerol, 2% ethanol, 2% bactopeptone, 1% yeast extract) that
was either untreated (EG) or supplemented with oligomycin to 0.2 µg/ml (EGO), and
incubated at 30 °C for 48 h. From top to bottom, the strains analyzed were W303-1A,
W303ΔATP11, andW303ΔATP11 transformants harboring plasmids for Atp11(R183)p,
Atp11(Δ40-111)p, Atp11(Δ40-75)p, or Atp11(A300)p. The amount of oligomycin-
sensitive ATPase activity measured in mitochondria isolated from each strain is shown
on the left. For stylistic reasons, two separate regions of the same photograph were
fused (white dotted line) to create the digital image of the EG and EGO plates shown in
the ﬁgure.
Fig. 6. The rate of ATP synthesis is linearly correlated with the cytochrome c oxidase
activity in yeast atp6 mutants. The diagram shows a linear correlation between the ATP
synthesis rate (expressed as % of the wild type activity) and cytochrome c oxidase
activity (expressed as % of the wild type activity) in Δatp6, atp6-L183P (T8993C), atp6-
L183R (T8993G), atp6-L247P (T9176C) and atp6-L247R (T9176G) strains.
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moderate but signiﬁcant deﬁcit (∼30%) in mitochondrial ATP
production. At ﬁrst glance, this reduction seemed to be caused, at
least in part, by defects in the assembly/stability of the ATP synthase.
Indeed, BN-analyses of atp6-L247P mitochondrial extracts revealed
the presence, in addition to fully assembled ATP synthase, of several
sub-complexes (Atp9p-ring, F1, and F1 α-subunit derivatives) that
were virtually absent in the wild type. The same types of sub-
complexes were observed previously in an ATP6-deletion strain
(Δatp6, [11]), in a mutant lacking the leader peptide of Atp6p [20],
and in yeast models of other NARP/MILS mutations (T9176G (atp6-
L247R) [8] and T8993C (atp6-L183P) [10]). Prior work showed that
large assemblies lacking Atp6p, but containing most of the other
subunits of the ATP synthase, formed in these mutants, but that these
assemblies were fragile and dissociated easily under the conditions of
BN-PAGE analysis [8,10,11]. Furthermore, in each case, the amounts of
assembled ATP synthase correlated with the steady-state levels of
Atp6p, presumably because Atp6p proteins have been shown to be
rapidly eliminated from the cells when they fail to assemble [24–27].
As Atp6p was efﬁciently synthesized in the atp6-L247P mutant
(Fig. 3), it can be inferred that it is the incorporation or stability of
Atp6p within the ATP synthase that is compromised in this mutant.
However, there was no obvious difference in the steady-state level of
Atp6p in atp6-L247P yeast compared with the wild type (Fig. 2C). It is
possible that, in vivo, Atp6p is incorporated in the ATP synthase of the
atp6-L247P mutant, but the association of the mutant protein is
unusually labile such that the complex dissociates partially when the
proteins are resolved in blue native gels.
The observed decrease in the capacity of oligomycin to inhibit the
mitochondrial ATPase activity in atp6-L247P yeast (60% versus 85% for
the wild type) provides further evidence that the enzyme is, in fact,
defective in the mutant strain. We propose that the difference in the
efﬁcacy of drug inhibition does not reﬂect a gain of resistance by the
mutant, since ATP synthesis was normally inhibited by oligomycin in
mitochondria from the atp6-L247P strain (Table 2). Instead, we
suggest that the coupling between the F1 and FO sectors is less efﬁcient
when the mutated ATP synthase works in the reverse mode. In this
respect, it must be noted that the ATPase assays are performed with
mitochondria in a hypotonic solution that is buffered at a non-
physiological pH (8.4), and in the presence of a large excess of ATP.
Under these conditions, the turnover of the F1FO complex is
approximately ten times that of the enzyme when it synthesizes
ATP. Considering the decreased stability of the F1FO complex of atp6-
L247P yeast, as revealed in BN-PAGE analyses (see above), it is
possible that in the extreme conditions of the ATPase assays, a sub-
population of the mutant complex dissociates and this provides free
F1-ATPase particles in the mitochondrial matrix that are no longer
sensitive to the effect of oligomycin interaction with FO. Instead under
the conditions of the ATP-driven proton translocation assays (Fig. 3),
more of the ATP synthase remains intact such that the magnitude of
oligomycin-sensitive coupled activity is comparable to what was
observed in wild type mitochondria.
The atp6-L247P mutant showed a decreased electron transfer
capacity that was correlated with a lower content in complex IV. We
propose that this is a secondary consequence of the defects in the ATP
synthase, as a similar relationship between respiratory activity and
complex IV levels was observed previously in other yeast models of
NARP/MILS mutations (atp6-L183P [10], atp6-L183R [9] and atp6-
L247R [8]) and in Δatp6 yeast [11]. Our current data, considered
together with what has been reported earlier, reveals an interesting
phenomenon. Notwithstanding the small number of mutations
analyzed, there is a linear correlation between the extent to which
ATP synthase activity is reduced with the prominence of a complex IV
deﬁcit (Fig. 6). These ﬁndings are relevant with respect to published
studies [8–11,28] that suggested complex IV biogenesis might be
controlled by the level of active ATP synthase, perhaps as a means toadjust the rate of electron transfer to the ATP needs of the cell or to
modulate themitochondrial membrane potential when glycolytic ATP
has to be imported into the organelle (i.e. anaerobic conditions) [29].
To date, there is no evidence to absolutely refute the hypothesis that
the amount of complex IV might be regulated by the rate of ATP
synthesis in human cells, as we propose might occur in yeast.
However, transient regulatory responses to the intramitochondrial
ATP/ADP ratio have been postulated to regulate cytochrome c oxidase
activity in mammals through adenine nucleotide binding to speciﬁc
sites on the enzyme (for a review see [30]). Hence, it appears that at
the very least, evolution has preserved complex IV as an important
target for the co-regulation of the electron transfer and ATP synthesis
activities in mitochondria.
Despite a 30% deﬁcit in mitochondrial ATP production, the yeast
atp6-L247P and atp6-L183P mutants grew like the wild type on non-
fermentable substrates, but ceased to proliferate by respiration if
limiting amounts of oligomycin was included in the medium. While
Atp6p is known to contribute to the binding of oligomycin [17], we
provide evidence that the increased sensitivity of these mutants to
oligomycin need not reﬂect a structural change in the oligomycin
binding pocket itself. The data presented in Fig. 5A and B show that
yeast deﬁcient for mitochondrial ATP synthase, due to mutations
unrelated to oligomycin binding (atp6-Δleader, atp11 variants), were
more sensitive to oligomycin relative to wild type strains. On this
basis, we propose that the respiratory capacity of atp6-L247P and
atp6-L183P mutants is unusually sensitive to oligomycin in vivo
because such strains are already partially compromised for ATP
synthesis. These ﬁndings are interesting in view of a previous study
that showed evidence for an oligomycin-induced genetic drift in favor
of wild type mtDNA in populations of human cells heteroplasmic for
the T8993G mutation [31]. The mechanism by which this genetic drift
occurs is poorly understood. Our observations support the possibility
that cells segregating less mutant mtDNA will be less vulnerable to
oligomycin because of an increase in their oxidative phosphorylation
capacity. Our ﬁndings are also interesting in view of the poor
correlations between genotype and phenotype expression for some
of the ATP6 pathogenic mutations, especially T9176C. Some of the
reported cases of this mutation were characterized by a relatively
mild phenotype [7] while others had an acute, severe clinical course
with fulminant Leigh syndrome and a sudden unexpected death [6].
Since the amount of mutated DNA was similar in the different
analyzed probands, it would appear that additional determinants may
be responsible for the differences in phenotypic presentation. The
synthetic lethality that is producedwhen ATP synthase deﬁcient yeast
1111R. Kucharczyk et al. / Biochimica et Biophysica Acta 1797 (2010) 1105–1112are exposed to levels of oligomycin that are below what is necessary
to prevent wild type growth on non-fermentable substrates illustrates
this concept.
In conclusion, notwithstanding the caveats in the extrapolation of
data from yeast to humans, we argue that the four ATP6 pathogenic
mutations created to model the human syndromes of NARP/MILS
(T8993G [9], T8993C [10], T9176G [8], and T9176C (this study)), have
similar impacts on the ATP synthase of yeast and human origins. This
idea is supported by the fact that amongst these mutations, the two
that have been shown to correlate with particularly severe forms of
the disease (T8993G, T9176G) were also much more detrimental in
yeast compared with T8993C and T9176C. Defective assembly/
stability of Atp6p was provided as the basis for the major deﬁcit in
ATP production imposed by the T9176G mutation both in yeast [8]
and in human cells [32,33]. In vivo, the T8993G mutation had
essentially no impact on the assembly/stability of yeast ATP synthase
[9], similarly to what has been reported in a thorough study of T8993G
cybrids [34]. However, other studies repeatedly demonstrated the
presence of partial ATP synthase assemblies in human tissues [35] or
cell lines [36] containing the T8993G mutation. T8993C cybrids have
been reported not to exhibit a defect in F1FO biogenesis [34]. However
this ﬁnding is at oddswith another study that revealed the presence of
free F1 in mitochondria of fresh muscle biopsies from T8993C patients
[37]. The latter observation mirrors what was reported for this
mutation in a yeast model [10]. The T9176C mutation, which is the
principal focus of the current paper, was not characterized in earlier
reports, to explain the reduction in ATP production in biopsies of fresh
muscle [38]. Very recently, defects identical to those reported here in
yeast, were found in ﬁbroblasts from patients who are homoplasmic
for the T9176C mutation (V. Proccacio et al., in preparation). These
similarities between yeast and humans likely reﬂect a strong
conservation of the Atp9p-ring/Atp6p structure, especially in the
region of Atp6p where the pathogenic mutations are located [2,4].
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